182 related articles for article (PubMed ID: 32890517)
21. Simultaneous integrated boost (SIB) to dominant intra-prostatic lesions during extreme hypofractionation for prostate cancer: the impact of rectal spacers.
Osman SOS; Fairmichael C; Whitten G; Lundy GS; Wesselman R; Wilson ML; Hounsell AR; Prise KM; Irvine D; McGarry CK; Jain S
Radiat Oncol; 2022 Feb; 17(1):38. PubMed ID: 35193630
[TBL] [Abstract][Full Text] [Related]
22. The Dollars and Sense of Hypofractionated Breast Radiation.
Ojerholm E; Freedman GM; Bekelman JE
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059429
[No Abstract] [Full Text] [Related]
23. Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis.
Ferella L; Limoncin E; Vittorini F; Chalaszczyk A; Sorce C; Grimaldi G; Franzese P; Ruggieri V; Varrassi E; Di Staso M; Gimenez De Lorenzo R; Marampon F; Tombolini V; Masciocchi C; Gravina GL
Crit Rev Oncol Hematol; 2019 Jul; 139():75-82. PubMed ID: 31112885
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic Ablative Body Radiotherapy for Intermediate- or High-Risk Prostate Cancer.
Loblaw A
Cancer J; 2020; 26(1):38-42. PubMed ID: 31977383
[TBL] [Abstract][Full Text] [Related]
25. Radiobiological rationale and clinical implications of hypofractionated radiation therapy.
Ko EC; Forsythe K; Buckstein M; Kao J; Rosenstein BS
Cancer Radiother; 2011 Jun; 15(3):221-9. PubMed ID: 21514198
[TBL] [Abstract][Full Text] [Related]
26. Determining the need and utilization of radiotherapy in cancers of the breast, cervix, lung, prostate and rectum: A population level study.
Shack L; Lu S; Weeks LA; Craighead P; Kerba M
Radiother Oncol; 2017 Jan; 122(1):152-158. PubMed ID: 28012795
[TBL] [Abstract][Full Text] [Related]
27. Extreme Hypofractionation with SBRT in Localized Prostate Cancer.
Gómez-Aparicio MA; Valero J; Caballero B; García R; Hernando-Requejo O; Montero Á; Gómez-Iturriaga A; Zilli T; Ost P; López-Campos F; Couñago F
Curr Oncol; 2021 Aug; 28(4):2933-2949. PubMed ID: 34436023
[TBL] [Abstract][Full Text] [Related]
28. Accelerated Adaptation of Ultrahypofractionated Radiation Therapy for Breast Cancer at the Time of the COVID-19 Pandemic.
Machiels M; Weytjens R; Bauwens W; Vingerhoed W; Billiet C; Huget P; Verellen D; Dirix P; Meijnders P; Poortmans P; Kaidar-Person O
Clin Oncol (R Coll Radiol); 2021 Mar; 33(3):e166-e171. PubMed ID: 33309183
[No Abstract] [Full Text] [Related]
29. New developments in radiation treatment.
Price A
Hosp Med; 1998 Dec; 59(12):931-5. PubMed ID: 10696354
[TBL] [Abstract][Full Text] [Related]
30. Comparative effectiveness research in radiation oncology: stereotactic radiosurgery, hypofractionation, and brachytherapy.
Aneja S; Yu JB
Semin Radiat Oncol; 2014 Jan; 24(1):35-42. PubMed ID: 24314340
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of oligometastatic or oligoprogression cancer].
Bourgier C; Latorzeff I; Fenoglietto P; Boisselier P; Charissoux M; Llacer C; Lemanski C; Riou O; Farcy-Jacquet MP; Azria D
Cancer Radiother; 2019 Oct; 23(6-7):482-485. PubMed ID: 31495737
[TBL] [Abstract][Full Text] [Related]
32. Recommendations for hypofractionated whole-breast irradiation.
; Freitas NMA; Rosa AA; Marta GN; Hanna SA; Hanriot RM; Borges ABB; Gondim GRM; Pellizzon ACA; Veras IM; Almeida Júnior WJ; Fernandez CRSHW; Batalha Filho ES; Castilho MS; Kuhnen FQ; Najas RMXF; Affonso Júnior RJ; Leite ACC; Ribeiro HLM; Freitas Junior R; Oliveira HF
Rev Assoc Med Bras (1992); 2018 Sep; 64(9):770-777. PubMed ID: 30672995
[TBL] [Abstract][Full Text] [Related]
33. Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL).
Murthy V; Mallick I; Gavarraju A; Sinha S; Krishnatry R; Telkhade T; Moses A; Kannan S; Prakash G; Pal M; Menon S; Popat P; Rangarajan V; Agarwal A; Kulkarni S; Bakshi G
BMJ Open; 2020 Feb; 10(2):e034623. PubMed ID: 32114475
[TBL] [Abstract][Full Text] [Related]
34. [Report on the 43rd Congress of the American Society for Therapeutic Radiology and Oncology (ASTRO), San Francisco, 4-8 November 2001].
Noël G; Mazeron JJ
Cancer Radiother; 2002 Feb; 6(1):50-8. PubMed ID: 11899681
[No Abstract] [Full Text] [Related]
35. Is there a limit to dose escalation for rectal cancer?
Cummings BJ
Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):730-7. PubMed ID: 17869492
[TBL] [Abstract][Full Text] [Related]
36. Evolution of definitive external beam radiation therapy in the treatment of prostate cancer.
Daly T
World J Urol; 2020 Mar; 38(3):565-591. PubMed ID: 30850855
[TBL] [Abstract][Full Text] [Related]
37. [Minutes of the 47th meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO). Denver, 16-20 October 2004].
Mazeron JJ
Cancer Radiother; 2005 Dec; 9(8):620-5. PubMed ID: 16325449
[No Abstract] [Full Text] [Related]
38. Radiation recall dermatitis triggered by inactivated COVID-19 vaccine.
Afacan E; Öğüt B; Üstün P; Şentürk E; Yazıcı O; Adışen E
Clin Exp Dermatol; 2021 Dec; 46(8):1582-1584. PubMed ID: 34080223
[No Abstract] [Full Text] [Related]
39. Ultrahypofractionated Radiotherapy for Localised Prostate Cancer: How Far Can We Go?
Corkum MT; Achard V; Morton G; Zilli T
Clin Oncol (R Coll Radiol); 2022 May; 34(5):340-349. PubMed ID: 34961659
[TBL] [Abstract][Full Text] [Related]
40. Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward.
Krug D; Baumann R; Combs SE; Duma MN; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Hehr T; Piroth MD; Sedlmayer F; Souchon R; Strnad V; Budach W;
Strahlenther Onkol; 2021 Apr; 197(4):269-280. PubMed ID: 33507331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
